300 related articles for article (PubMed ID: 29801583)
1. Pharmacogenetics of Antidiabetic Drugs.
Srinivasan S; Yee SW; Giacomini KM
Adv Pharmacol; 2018; 83():361-389. PubMed ID: 29801583
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.
Staiger H; Schaeffeler E; Schwab M; Häring HU
Rev Diabet Stud; 2015; 12(3-4):363-76. PubMed ID: 27111121
[TBL] [Abstract][Full Text] [Related]
3. The pharmacogenetics of type 2 diabetes: a systematic review.
Maruthur NM; Gribble MO; Bennett WL; Bolen S; Wilson LM; Balakrishnan P; Sahu A; Bass E; Kao WH; Clark JM
Diabetes Care; 2014; 37(3):876-86. PubMed ID: 24558078
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
Florez JC
Diabetologia; 2017 May; 60(5):800-807. PubMed ID: 28283684
[TBL] [Abstract][Full Text] [Related]
5. Precision medicine: The future in diabetes care?
Scheen AJ
Diabetes Res Clin Pract; 2016 Jul; 117():12-21. PubMed ID: 27329017
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine.
Mannino GC; Andreozzi F; Sesti G
Diabetes Metab Res Rev; 2019 Mar; 35(3):e3109. PubMed ID: 30515958
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of oral antidiabetic therapy.
Ordelheide AM; Hrabě de Angelis M; Häring HU; Staiger H
Pharmacogenomics; 2018 Apr; 19(6):577-587. PubMed ID: 29580198
[TBL] [Abstract][Full Text] [Related]
8. A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes.
Damanhouri ZA; Alkreathy HM; Alharbi FA; Abualhamail H; Ahmad MS
Int J Med Sci; 2023; 20(1):142-150. PubMed ID: 36619226
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of Type 2 Diabetes-Progress and Prospects.
Nasykhova YA; Tonyan ZN; Mikhailova AA; Danilova MM; Glotov AS
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961860
[TBL] [Abstract][Full Text] [Related]
10. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.
Vashisht R; Jung K; Schuler A; Banda JM; Park RW; Jin S; Li L; Dudley JT; Johnson KW; Shervey MM; Xu H; Wu Y; Natrajan K; Hripcsak G; Jin P; Van Zandt M; Reckard A; Reich CG; Weaver J; Schuemie MJ; Ryan PB; Callahan A; Shah NH
JAMA Netw Open; 2018 Aug; 1(4):e181755. PubMed ID: 30646124
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacogenetics of oral antidiabetic treatment].
Tkáč I
Vnitr Lek; 2016 Mar; 62(3):186-8. PubMed ID: 27180666
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics and personalized treatment of type 2 diabetes.
Semiz S; Dujic T; Causevic A
Biochem Med (Zagreb); 2013; 23(2):154-71. PubMed ID: 23894862
[TBL] [Abstract][Full Text] [Related]
13. Metformin transporter pharmacogenomics: insights into drug disposition-where are we now?
Chan P; Shao L; Tomlinson B; Zhang Y; Liu ZM
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1149-1159. PubMed ID: 30375241
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of new classes of antidiabetic drugs.
Imamovic Kadric S; Kulo Cesic A; Dujic T
Bosn J Basic Med Sci; 2021 Dec; 21(6):659-671. PubMed ID: 33974529
[TBL] [Abstract][Full Text] [Related]
15. Understanding the Pathogenesis, Therapeutic Targets/Drug Action and Pharmacogenetics of Type 2 Diabetes: Is there a Future for Personalised Medicine?
Engwa GA; Nweke FN; Karngong GN; Afiukwa CA; Nwagu KE
Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1569-1589. PubMed ID: 32334506
[TBL] [Abstract][Full Text] [Related]
16. The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes.
Walford GA; Colomo N; Todd JN; Billings LK; Fernandez M; Chamarthi B; Warner AS; Davis J; Littleton KR; Hernandez AM; Fanelli RR; Lanier A; Barbato C; Ackerman RJ; Khan SQ; Bui R; Garber L; Stolerman ES; Moore AF; Huang C; Kaur V; Harden M; Taylor A; Chen L; Manning AK; Huang P; Wexler D; McCarthy RM; Lo J; Thomas MK; Grant RW; Goldfine A; Hudson MS; Florez JC
PLoS One; 2015; 10(3):e0121553. PubMed ID: 25812009
[TBL] [Abstract][Full Text] [Related]
17. "The pharmacological profile of SGLT2 inhibitors: Focus on mechanistic aspects and pharmacogenomics".
Kaur P; Behera BS; Singh S; Munshi A
Eur J Pharmacol; 2021 Aug; 904():174169. PubMed ID: 33984301
[TBL] [Abstract][Full Text] [Related]
18. A Polygenic Score for Type 2 Diabetes Risk Is Associated With Both the Acute and Sustained Response to Sulfonylureas.
Li JH; Szczerbinski L; Dawed AY; Kaur V; Todd JN; Pearson ER; Florez JC
Diabetes; 2021 Jan; 70(1):293-300. PubMed ID: 33106254
[TBL] [Abstract][Full Text] [Related]
19. Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 Diabetes.
Heo CU; Choi CI
J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30901912
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of metformin response: a step in the path toward personalized medicine.
Reitman ML; Schadt EE
J Clin Invest; 2007 May; 117(5):1226-9. PubMed ID: 17476355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
